Fierce is looking for the biggest Rising Stars in Health Tech
We’re searching for the engineers and designers who are looking to deliver on the beneficial potential of AI and new technologies in healthcare.
Biotech Hub
Spectrum cuts 30% of its workforce and some R&D to focus on 2 key cancer meds
Spectrum Pharmaceuticals has weathered changes and challenges in recent years, including a sale of its marketed drugs portfolio in 2019 and an FDA rejection for a key prospect last year. Now, it’s…
Intellia bags option on autoimmune CAR-T prospect, handing Kyverna rights to use CRISPR tech to create off-the-shelf cell therapy
Intellia Therapeutics has found a new CAR-T use for its CRISPR/Cas9 platform: autoimmune diseases. By teaming up with Kyverna Therapeutics, Intellia has secured an option on an allogeneic anti-CD19…
Fighting drug-resistant cancer by blocking an escape pathway
Chemotherapy and radiation kill cancer cells by inducing significant DNA damage beyond repair. But some tumors still develop alternative ways to survive. Now, scientists have identified such a…
Owlet, Kiddo ramp up remote health monitoring offerings for babies and children
Both Owlet and Kiddo kicked off the new year with an eye toward growth—in the form of a new product launch for the former and the largest venture funding round yet for the latter.
Ultragenyx granted go-ahead to up doses for Angelman antisense therapy that stalled after safety issues
Ultragenyx Pharmaceutical and partner GeneTx Biotherapeutics have been given the go-ahead to up the dose in a phase 1/2 Angelman syndrome trial of antisense treatment GTX-102 that was previously…
With Vera Whole Health’s $370M purchase, Castlight Health to go private
Vera, a value-based primary care provider, will buy all the outstanding shares of Castlight, in a move that will merge the two companies.
Dr. Danny Sands, Author at MedCity News
Dr. Danny Sands For over twenty years Danny Sands, MD has worked at the intersection of health care, technology, and business. His career began at Beth Israel Deaconess Medical Center, where he trained in clinical informatics and went on to develop and implement numerous systems to improve clinical care delivery and patient engagement. He has …
Craig Ahrens, Author at MedCity News
Craig Ahrens Craig Allan Ahrens, SVP of Strategy and Growth for CareRev, is an innovative voice in a traditional industry. His background and vision offer a fresh perspective on the relationship between the healthcare sector and technology investment. As a healthcare innovation/startup leader, consultant, and digital health transformation executive, he brings more than 20 years …
VCs plow $115M into next-gen genetic medicine startup SalioGen, teeing up work on eye and liver diseases
SalioGen Therapeutics is moving quickly. Ten months after exiting stealth with $20 million in series A funds, the Massachusetts-based biotech has raised another $115 million to fund its vision of the…